Alka Chaubey
Equibles does not estimate personal net worth.
About Alka Chaubey
Bionano Genomics, Inc. reported in an 8-K filed June 5, 2026 that Alka Chaubey resigned as Chief Medical Officer, effective July 5, 2026. The proxy statement of Bionano Genomics, Inc. reports total compensation of $756,329 for Alka Chaubey in fiscal 2025, including a base salary of $460,000. Disclosed compensation is on record for 4 fiscal years.
“On June 2, 2026, Alka Chaubey, Ph.D. resigned as Chief Medical Officer of Bionano Genomics, Inc. (the "Company") effective July 5, 2026.”
Affiliation history
-
Bionano Genomics, Inc. (BNGO)
Proxy statement
Start not stated–2026-07-05
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Bionano Genomics, Inc. (BNGO) | Ph.D., FACMG Chief Medical Officer | $460,000 | $756,329 |
| 2024 | Bionano Genomics, Inc. (BNGO) | Ph.D., FACMG Chief Medical Officer | $459,615 | $661,908 |
| 2023 | Bionano Genomics, Inc. (BNGO) | Ph.D., FACMG Chief Medical Officer | $439,231 | $864,780 |
| 2022 | Bionano Genomics, Inc. (BNGO) | Ph.D., FACMG Chief Medical Officer | $399,269 | $1,317,829 |